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Mycobacterium nonchromogenicum
Bacteremia in an AIDS Patient
To the Editor: Mycobacterium avium complex is
the most common nontuberculous mycobacterium
that causes disseminated infection in HIV-
positive patients (1). Other less common
nontuberculous mycobacteria responsible for
disseminated disease in these patients are M.
fortuitum (2), M. genavense (3), M. gordonae (4),
M. haemophilum (5), M. kansasii (6), M.
malmoense (7), M. marinum (8), M. scrofulaceum
(9), M. simiae (10), M. szulgai (11), M. terrae (9),
and M. xenopi (2,9). Although only M. genavense,
M. kansasii, and M. xenopi are significantly more
frequent in these patients (2,3,9), HIV infection is
likely a predisposing condition for all
nontuberculous mycobacterial infections. We
report the first case of disseminated infection
caused by M. nonchromogenicum in an HIV-
infected patient.
A 28-year-old man with HIV infection
acquired by sharing injection tools was seen in
our outpatient clinic because of intermittent
fever, drenching nocturnal sweats, and cough
with purulent sputum of 4 months’ duration. He
also reported a weight loss of 10 kg in the
previous 2 months. He had been diagnosed with
bronchial infection in another hospital and had
been treated with an unknown antibiotic. After
this treatment, respiratory symptoms had
improved somewhat, but fever and constitutional
symptoms continued. His only previous opportu-
nistic infection had been recurrent oral and
esophageal candidiasis. The last CD4-cell count
had been 16/mL 1 year earlier, and he was
receiving didanosine and prophylactic therapy
with cotrimoxazole and fluconazole. On physical
examination the patient appeared ill; he was
febrile, cachectic, and had thrush and oral hairy
leukoplakia. Neither lymphadenopathy nor
abnormal cardiopulmonary symptoms were
found. The liver, which had enlarged since the
last examination, was palpated 6 cm below the
right costal margin. Abnormal laboratory values
included aspartate aminotransferase 61 U/L,
gamma-glutamyl transferase 209 U/L, lactate
dehydrogenase 516 U/L, hemoglobin 12.3 g/dL,
leukocyte count 4,300/mL (66% neutrophils, 19%
band forms, 1% metamyelocytes, 3% lympho-
cytes, 11% monocytes), platelet count 130,000/mL,
and erythrocyte sedimentation rate 72 mm/h.
Chest X-rays were unremarkable, and a set of
blood cultures was sterile. A sputum culture
yielded Haemophilus influenzae sensitive to
ampicillin, and smears and cultures for mycobac-
teria in one stool and three sputum samples were
negative.
The patient was treated with oral amoxicillin
for 2 weeks without improvement. Empirical
therapy against M. avium complex with
clarithromycin, ciprofloxacin, and ethambutol
was started; the patient’s condition improved
dramatically within the next few days, and the
fever and diaphoresis disappeared, although
cough and sputum production remained un-
changed. Three weeks later, a slow-growing
nonphotochromogenic mycobacterium, identified
as  M. nonchromogenicum in a reference
laboratory (Centro Nacional de Microbiología,
Majadahonda, Madrid, Spain) by biochemical
tests and confirmed by polymerase chain
reaction-restriction enzyme pattern analysis,
was isolated from a blood sample obtained on
admission. This microorganism was sensitive to
the three drugs administered, and the treatment
was continued. Two months later the patient had
gained 10 kg, hemoglobin had increased to 13.8
g/dL, the erythrocyte sedimentation rate had
decreased to 52 mm/h, and the differential
leukocyte count had returned to normal.
Antimycobacterial drugs were withheld after 1
year of treatment. Twenty-two months after the
diagnosis, the patient is doing well. He is
receiving combination antiretroviral therapy,
and his CD4-cell count is 128/mL.
M. nonchromogenicum, a slow-growing non-
pigmented (Runyon’s group III) mycobacterium,
belongs to the M. terrae complex, together with
M. triviale; it is traditionally considered
nonpathogenic. However, it has been involved in
a few cases of pulmonary infection (12) and
chronic tenosynovitis secondary to puncture
wounds (13), like the related organism M. terrae.
In fact, some authors think that M.
nonchromogenicum is the true pathogen in the
M. terrae complex (13), and it is possible that
some reports have misidentified this organism.
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from radishes, but it has been found to be
ubiquitous in the aquatic environment, including
a hospital potable water supply (14).
Unlike osteoarticular infections, which
commonly occur in previously healthy people,
the scanty reports on pulmonary and dissemi-
nated infection by M. terrae complex suggest
that either immunosuppression or local predis-
posing conditions (e.g., tuberculous cavities)
are necessary pathogenetic cofactors (15). To
our knowledge, M. nonchromogenicum bacter-
emia has never been reported before.
No specific DNA probes exist for M. terrae
complex, but false-positive reactions with M.
tuberculosis complex DNA probes have been
described (16). Isolates are usually resistant to most
antituberculosis drugs, with the exception of
ethambutol and streptomycin, and susceptible to
erythromycin, ciprofloxacin, and sulfonamides.
Only one case of disseminated infection by M.
terrae has been described in a patient with
advanced HIV infection and positive cultures in
blood and bronchoalveolar lavage fluid, but no
additional data were provided (9). Although the
isolate we recovered might represent a labora-
tory contaminant, several pieces of evidence
make this possibility very unlikely: lack of
alternative explanation for a persistent and
progressive clinical picture of 4 months’ duration,
absence of response to standard antibiotic therapy,
negative results in the search for other pathogens,
rapid and sustained clinical and laboratory
response to drugs active against this strain, clear
improvement despite the lack of treatment for
other conditions, and absence of other isolates of
this pathogen in our hospital despite the large
number of samples examined for mycobacteria.
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